Copyright
©The Author(s) 2021.
World J Clin Oncol. Jul 24, 2021; 12(7): 557-564
Published online Jul 24, 2021. doi: 10.5306/wjco.v12.i7.557
Published online Jul 24, 2021. doi: 10.5306/wjco.v12.i7.557
Figure 1 Timeline of neoadjuvant and perioperative therapies in patients with esophagogastric junction cancer.
MAGIC: The British Medical Research Council Adjuvant Gastric Infusional Chemotherapy; CROSS: ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
- Citation: Laxague F, Schlottmann F. Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy? World J Clin Oncol 2021; 12(7): 557-564
- URL: https://www.wjgnet.com/2218-4333/full/v12/i7/557.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i7.557